VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$3.19
+0.10 (+3.24%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+200.6% upside
Low Target
$7.88
Average Target
$9.59
High Target
$13.36
Current Price
$3.19
Current
$3.19
$3.19
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Scenario Analysis
Bear Case
$7.88
147.0%
Low target
Base Case
$9.59
+200.6%
Avg target
Bull Case
$13.36
+318.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.82
-67.5% from high
52-Week Low
$3.08
+3.6% from low
Target vs 52W High
$9.59
-2.4% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-0.51
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals